Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Seres Therapeutics Second Quarter 2025 Results and Business Update Call. [Operator Instructions] Please note, this call is being recorded.